The recent correction in semiconductor stocks like Micron (MU) and Samsung represents a strategic buying opportunity, with MU projected to reach significant long-term highs as consumer AI agents drive a 30x increase in compute demand. Investors should maintain high conviction in Apple (AAPL) and Meta (META) as they reprice higher to reflect their dominance in the emerging consumer AI assistant market. In the healthcare sector, Eli Lilly (LLY) remains a "never sell" core holding due to its aggressive integration of sovereign AI for drug discovery. Bitcoin (BTC) is currently at the bottom of its range and is expected to exceed $100,000 within a year, especially if the Fed pauses rate hikes. Finally, monitor Regional Bank ETFs for M&A activity, as larger institutions acquire mid-sized banks to implement AI-driven cost reductions.

Artificial Intelligence (AI) & Semiconductors

The discussion highlights a transition from an "infrastructure build-out" phase to a "consumer agent" phase. The guest, Jordi Visser, argues that the "AI mid-cycle slowdown" is over, suggesting that recent corrections in stock prices represent a buying opportunity rather than a bubble bursting.

• Compute Demand: There is a fundamental supply-demand mismatch. While some fear excess compute capacity, Visser argues demand is exponential because intelligence usage increases with every model advancement.
• Consumer Agents vs. Coding Agents: Consumer agents (e.g., AI booking trips, managing personal commerce) are estimated to consume 30x more compute than current coding agents.
• Model Commoditization: High-end models (OpenAI, Anthropic) will dominate the enterprise/high-IQ space, while others (Meta, Google, Apple) will focus on personal assistants and consumer integration.
• ROIC (Return on Invested Capital): The market is beginning to price in the actual revenue generation from AI, moving beyond mere speculation.

Takeaways

• NVIDIA (NVDA) & Infrastructure: Remain bullish on the "receivers" of infrastructure spending, though the "easy money" phase may be transitioning to a more volatile period.
• Micron (MU) & Samsung: Visser views the recent 20-30% corrections as healthy "leverage wipeouts." He predicts Micron could eventually reach $4,000–$5,000 long-term, though it will be a volatile ride.
• Apple (AAPL) & Meta (META): Bullish sentiment on Apple following its "Apple Intelligence" announcement. Visser suggests these stocks must be "repriced" higher as consumer agents drive new ROIC.
• Palantir (PLTR): Mentioned as a key player promoting enterprise-grade AI safety and integration, benefiting from the "price discovery" phase of AI deployment.

Bitcoin (BTC) & Crypto

Visser suggests that Bitcoin has acted as a "funding source" for the AI trade (investors selling BTC to buy AI stocks), but this trend is reversing.

• Bottoming Signal: Technical indicators (RSI divergence) suggest Bitcoin is at the bottom end of its current range.
• Rate Hike Expectations: If the Fed does not raise rates in late July, Bitcoin could quickly move above $70,000.
• Agentic Commerce: As AI agents begin to perform transactions, they will require digital, programmable money (crypto/stablecoins) to function efficiently.
• Tokenization: A major multi-year theme where "dormant assets" like real estate are liquefied through blockchain technology.

Takeaways

• Price Target: Visser expects Bitcoin to be above $100,000 a year from now.
• Entry Strategy: Current levels (around $60k) are considered the "bottom end of the range." Even if it dips to $45k–$50k, the long-term trajectory is viewed as bullish.
• Dogecoin (DOGE): Mentioned as a ticker to watch specifically for gauging the "energy" and retail sentiment within the crypto ecosystem.
• MicroStrategy (MSTR): The recent selling by Michael Saylor is viewed as "noise." The fact that the price held up after the news is considered a bullish signal.

Healthcare & Biotech

A strong emphasis was placed on the intersection of AI and healthcare, specifically "Sovereign AI" where companies own their own compute and models.

• Eli Lilly (LLY): Visser maintains a high-conviction "never sell" stance on Eli Lilly.
• Sovereign AI: Companies like Eli Lilly are using massive internal compute (e.g., NVIDIA Blackwell chips) to accelerate drug discovery and biotech partnerships.

Takeaways

• Investment Theme: Look for large-cap healthcare companies that are aggressively integrating AI to solve "physics and science problems" (e.g., curing diseases).

Financials & Commodities

• Regional Banks: Bullish outlook due to potential consolidation. Larger banks may acquire mid-sized banks to "infuse them with AI" and drastically reduce headcount/operating costs.
• Insurance: A sector expected to see significant margin improvement as AI agents streamline claims and underwriting.
• Gold & Silver: Expected to rise as the "debasement trade" returns and the "AI capital suck" (money leaving gold for AI) stabilizes.
• Oil: Bearish/Neutral sentiment. Visser suggests oil acts as if there is a "glut" and could head toward $50 long-term as AI helps solve energy efficiency and alternative energy problems.

Takeaways

• Action: Monitor Regional Bank ETFs for M&A activity driven by AI efficiency gains.
• Hedge: Use Gold and Silver as a play on the continued US budget deficit and potential Fed pivot.

Robotics

• 1X Technologies: Mentioned for their breakthrough in "tendon-based" robotic hands, allowing for human-like dexterity (e.g., picking a cherry without crushing it).
• Compounding Intelligence: AI is now solving the hardware limitations of robotics. Visser predicts a future with "billions of robots" as AI-driven design accelerates.

Takeaways

• Theme: The "Humanoid" market is the next frontier. As AI moves from "language" (LLMs) to "physics" (Robotics), companies involved in robotic components and AI-integrated hardware will see massive growth.